Our company
The Cygnus Pharmaceutical group was founded in the Republic of Bulgaria in 2017.
The company has partnering relationships and a great deal of contracts with the leading pharmaceutical factories of the European Union and China. The activity area of the company is the pharmaceutical raw materials selling . In 2019, we've decided to release own line of hormonal drugs.
Mission
Our mission is very clear - provide best and fully tested products and to be useful for our customers
We offer details on each of our products so that users can understand the products fully and seek the proper usage in regards to each product. We keep to the strictest security and privacy standards to save your personal information and the one of e-commerce.
Passion
We are professional and You will always Receive First Class Service.
We love to care about the people because by choosing our products you are giving us a chance to change a small part of your world and we are happy to do that professionally and passionately
Welcome to The Cygnus Pharmaceutical group
Based on your feedback, we are improving our products
and expanding the range of products depending on your needs and demands.
Official distributors
Happy clients
Own products
Rating comments
We analyse your needs carefully
Our company has the most precise requirements and manufacturing guidelines in terms of quality. We have invested in smarter manufacturing, putting lean, six sigma PAT and QbD principles into routine practice. In order to ensure precise manufacturing and formulation development, almost every process can be automated. But achieving success is not just about process, robust analytical information is key.
We provide best solutions
We work on daily basis to improve and enhance their national health grade by supplying formulations manufactured with high purity grade ingredients such as: injectables and tablets. The acquired knowledge led the Company to add the custom synthesis as an additional service provided to those customers aiming to find a long term partner for the development of both patented and off patented molecules.